Search
Session handouts and meetings archive
View previous AAD meeting sessions, handouts, poster exhibits, and floor plans.
Key messages to communicate about Indoor tanning
By communicating these key messages on indoor tanning, you can help position the specialty while increasing your credibility and raising the profile of your practice.
CME & session evaluation archive
Claim CME credit and submit session evaluations for attending previous Academy meetings.
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform.
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
Advocacy Update Feb. 4 2025
The AADA is pleased that physician champions in the U.S. House introduced a bipartisan bill to address the 2025 Medicare Physician Fee Schedule cut.
Advocacy Update June 30, 2026
AADA President Murad Alam, MD, MSCI, MBA, FAAD, met with federal legislators on Medicare physician payment reform in Washington, DC.
Advocacy Update May 5, 2026
In response to advocacy by the AADA and other specialty societies, UnitedHealth Care will delay any adverse payment decisions related to Medicare Advantage referral requirements starting on May 1.
Herpes zoster, immunosuppression, and vaccination: Far from a blistering pace
I had long promised myself that I would get Zostavax when I turned 60. Now 61, I am actively procrastinating – I decided to wait for a new VZV subunit zoster vaccine that consists of recombinant VZV glycoprotein E and a liposome-based ASO1B adjuvant system.
Taking the challenge: Social media, adolescents, and the skin
Learn more about Taking the challenge: Social media, adolescents, and the skin at aad.org
Advocacy Update Dec 9, 2025
The AADA endorsed a House bill that would include an annual inflationary update to the Medicare physician fee schedule, the Academy’s top federal advocacy priority.
Advocacy Update Feb. 18 2025
The AADA joined over 130 national and state physician organizations led by the AMA demanding Congress act to reform Medicare physician payment.
Advocacy Update Mar. 18, 2025
The AADA is outraged that Congress once again passed a government funding bill that did not include relief to stop this year’s 2.8% Medicare physician payment cut.
Coming to an ICU Near You — Candida auris
I first became aware of Candida auris (C. auris) during my 96 year-old mother’s most recent hospitalization in New York for congestive heart failure.
Slammed by slime
Read the September 16, 2020 DWII on "slime" and its dermatological impacts.
Glucose monitors: Not as sweet as they seem
Learn more about Glucose monitors: Not as sweet as they seem at aad.org
Prior authorization audits and innovations: Are we finally reducing the (PA)in?
Much data supports the inefficiency and poor clinical outcomes related to impractical prior authorization (PA) implementation. There are numerous resources, including your own office/department (e.g., hiring a clinical pharmacist) and state (e.g., local medical societies) and federal (e.g., AMA) organizations to provide frameworks and enact laws to reduce the administrative
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
Read the June 17, 2020 DermWorld Insights and Inquiries on capillary malformation.
A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma
he clinically distinctive medallion-like dermal dendrocyte hamartoma is a benign lesion that must be differentiated from congenital atrophic dermatofibrosarcoma protuberans, especially in patients with adenosine deaminase-deficient severe combined immunodeficiency.
Preferentially expressed antigen in melanoma (PRAME)
The immunohistochemical study PRAME is increasing utilized in the diagnosis of challenging melanocytic lesions.
Recognizing Trichophyton indotineae
In the last decade, a recently emerged dermatophyte species, Trichophyton indotineae, has been causing major outbreaks of severe, difficult-to-treat, and frequently relapsing infections in South Asia among immunocompetent patients.
Time to reassess messing around with steroids and psoriasis
Read the March 3, 2021 DermWorld Insights and Inquiries on reassessing steroids and psoriasis.
Adding protothecosis to the protocol
Protothecosis presents as a localized cutaneous infection, olecranon bursitis, or disseminated disease, especially in immunocompromised patients. Although rare, there have been increasing reports of the disease. Dermatologists should consider this diagnosis in patients presumed to have recalcitrant infectious disorders.
Saving face: The importance of recognizing facial discoid dermatosis
Read the Feb. 22, 2023 DermWorld Insights and Inquiries on recognizing facial discoid dermatosis.
Cannabis arteritis: Getting higher on the differential diagnosis list of ulcerative lesions
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, January 1, 2026 Vol. 8, No. 1 Marijuana use is on the rise. In 2022, nearly 22% of people had used the drug in the past year, with steep increases in the number of people 65 and older who
Complications of silicone injections: persistence, stigma, and treatment
Read the Jan. 18, 2023 DermWorld Insights and Inquiries on complications of silicone injections.
Biotin supplementation for hair and nail health: Does it pass the test?
Read the November 17, 2021 DermWorld Insights and Inquiries on biotin supplementation for hair and nail health.
After 23 years, a syndrome converted me into an eflornithine believer
Polyamines are integrally involved with the hair cycle. The Bachmann-Bupp syndrome has shed new light on the role of ornithine decarboxylase, and how it’s inhibition by eflornithine can be used as an advantage to either slow or stimulate hair growth.
Assessing the significance of a Long-Developed Habit: The role of LDH in dermatology
Read the July 14, 2021 DermWorld Insights and Inquiries on assessing the significance of LDH in dermatology.
Do not get burned by missing Staphylococcal scalded skin syndrome
Read the April 28, 2021 DermWorld Insights and Inquiries on Staphylococcal scalded skin syndrome.
The Venetian antithesis: Treating median canaliform nail dystrophy
Median canaliform nail dystrophy is easy to recognize but difficult to treat. Recent reports utilizing tazarotene foam, dupilumab, and marigold offer some promise that warrant further study with appropriate trials.
Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?
Read the December 8, 2021 DermWorld Insights and Inquiries on propranolol and neutrophilic dermatoses.
Is it a waste for dermatologists to order fecal calprotectin?
Read the June 22, 2022 DermWorld Insights and Inquiries on whether it is a waste for dermatologists to order fecal calprotectin.
A shot in the dark
Read the March 10, 2021 DermWorld Insights and Inquiries on COVID arm.
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
Read the Aug. 17, 2022 DermWorld Insights and Inquiries on cutaneous lupus erythematosus and interferon.
The profound dermatological manifestations of COVID-19 Part VI: Going to the dogs
Read the July 29, 2020 DermWorld Insights and Inquiries on the COVID-19 pandemic.
Dermatologists should not be in the dark about kratom
Kratom use has been dramatically increasing in the United States. Dermatologists may be the first to recognize it because of a photodistributed hyperpigmentation. Diagnostic confirmation is by history, not laboratory analysis. Rendering the diagnosis allows dermatologists to refer patients for appropriate social, psychiatric, and medical care.
The nexus of VEXAS syndrome
Read the December 1, 2021 DermWorld Insights and Inquiries on VEXAS syndrome.
CXCR4 antagonist therapy based on a WHIM syndrome
Advances in understanding the pathomechanisms of WHIM syndrome are the prelude to treating this syndrome — and other diseases — with CXCR4 antagonists.
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
FcRn antagonists, currently approved for treating myasthenia gravis, show potential for treating pemphigus and other autoimmune diseases.
Short anagen syndrome: The long and short of it
Short anagen syndrome (SAS) is an underrecognized disorder usually observed in children and typically resolves after puberty. It may be accompanied by psychological distress. Topical minoxidil and oral biotin may help therapeutically. Novel research has associated WNT10A variants with SAS and male pattern alopecia, opening the door for new areas